BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35037799)

  • 21. Machine learning based on clinical characteristics and chest CT quantitative measurements for prediction of adverse clinical outcomes in hospitalized patients with COVID-19.
    Feng Z; Shen H; Gao K; Su J; Yao S; Liu Q; Yan Z; Duan J; Yi D; Zhao H; Li H; Yu Q; Zhou W; Mao X; Ouyang X; Mei J; Zeng Q; Williams L; Ma X; Rong P; Hu D; Wang W
    Eur Radiol; 2021 Oct; 31(10):7925-7935. PubMed ID: 33856514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study.
    Gimeno-Miguel A; Bliek-Bueno K; Poblador-Plou B; Carmona-Pírez J; Poncel-Falcó A; González-Rubio F; Ioakeim-Skoufa I; Pico-Soler V; Aza-Pascual-Salcedo M; Prados-Torres A; Gimeno-Feliu LA;
    PLoS One; 2021; 16(11):e0259822. PubMed ID: 34767594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry.
    Sokolski M; Trenson S; Reszka K; Urban S; Sokolska JM; Biering-Sørensen T; Højbjerg Lassen MC; Skaarup KG; Basic C; Mandalenakis Z; Ablasser K; Rainer PP; Wallner M; Rossi VA; Lilliu M; Loncar G; Cakmak HA; Ruschitzka F; Flammer AJ
    Cardiol J; 2024 Jun; ():. PubMed ID: 38832553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
    Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
    JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study.
    Xiong TY; Huang FY; Liu Q; Peng Y; Xu YN; Wei JF; Li N; Bai B; Li JH; Prendergast B; Li WM; Chen M
    Ann Med; 2020 Nov; 52(7):361-366. PubMed ID: 32716217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19.
    Papa A; Covino M; Pizzolante F; Miele L; Lopetuso LR; Bove V; Iorio R; Simeoni B; Vetrone LM; Tricoli L; Mignini I; Schepis T; D'Alessandro A; Coppola G; Nicoletti T; Visconti E; Rapaccini G
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7506-7511. PubMed ID: 32706091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
    Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
    Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 patients followed in Portuguese Primary Care: a retrospective cohort study based on the national case series.
    Tenreiro P; Ramalho A; Santos P
    Fam Pract; 2022 Jan; 39(1):52-58. PubMed ID: 34448861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
    Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
    Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.
    Mah J; Lieu A; Palayew M; Alipour P; Kong LY; Song S; Palayew A; Tutt-Guérette MA; Yang SS; Wilchesky M; Lipes J; Azoulay L; Greenaway C
    CMAJ Open; 2021; 9(3):E718-E727. PubMed ID: 34257090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study.
    Riyahi S; Dev H; Behzadi A; Kim J; Attari H; Raza SI; Margolis DJ; Jonisch A; Megahed A; Bamashmos A; Elfatairy K; Prince MR
    Radiology; 2021 Dec; 301(3):E426-E433. PubMed ID: 34254850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study.
    Paris S; Inciardi RM; Lombardi CM; Tomasoni D; Ameri P; Carubelli V; Agostoni P; Canale C; Carugo S; Danzi G; Di Pasquale M; Sarullo F; La Rovere MT; Mortara A; Piepoli M; Porto I; Sinagra G; Volterrani M; Gnecchi M; Leonardi S; Merlo M; Iorio A; Giovinazzo S; Bellasi A; Zaccone G; Camporotondo R; Catagnano F; Dalla Vecchia L; Maccagni G; Mapelli M; Margonato D; Monzo L; Nuzzi V; Pozzi A; Provenzale G; Specchia C; Tedino C; Guazzi M; Senni M; Metra M
    Europace; 2021 Oct; 23(10):1603-1611. PubMed ID: 34297833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covid-19 in liver transplant recipients: the French SOT COVID registry.
    Dumortier J; Duvoux C; Roux O; Altieri M; Barraud H; Besch C; Caillard S; Coilly A; Conti F; Dharancy S; Durand F; Francoz C; Garaix F; Houssel-Debry P; Kounis I; Lassailly G; Laverdure N; Leroy V; Mallet M; Mazzola A; Meunier L; Radenne S; Richardet JP; Vanlemmens C; Hazzan M; Saliba F; ;
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101639. PubMed ID: 33636654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.
    Lombardi CM; Carubelli V; Iorio A; Inciardi RM; Bellasi A; Canale C; Camporotondo R; Catagnano F; Dalla Vecchia LA; Giovinazzo S; Maccagni G; Mapelli M; Margonato D; Monzo L; Nuzzi V; Oriecuia C; Peveri G; Pozzi A; Provenzale G; Sarullo F; Tomasoni D; Ameri P; Gnecchi M; Leonardi S; Merlo M; Agostoni P; Carugo S; Danzi GB; Guazzi M; La Rovere MT; Mortara A; Piepoli M; Porto I; Sinagra G; Volterrani M; Specchia C; Metra M; Senni M
    JAMA Cardiol; 2020 Nov; 5(11):1274-1280. PubMed ID: 32845276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of mortality among long-term care residents with SARS-CoV-2 infection.
    Lee DS; Ma S; Chu A; Wang CX; Wang X; Austin PC; McAlister FA; Kalmady SV; Kapral MK; Kaul P; Ko DT; Rochon PA; Schull MJ; Rubin BB; Wang B;
    J Am Geriatr Soc; 2021 Dec; 69(12):3377-3388. PubMed ID: 34409590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the demographic characteristics and comorbidities of patients with COVID-19 who died in Spanish hospitals based on whether they were or were not admitted to an intensive care unit.
    Miró Ò; Alquézar-Arbé A; Llorens P; Martín-Sánchez FJ; Jiménez S; Martín A; Burillo-Putze G; Jacob J; García-Lamberechts EJ; Piñera P; Del Castillo JG;
    Med Intensiva (Engl Ed); 2021; 45(1):14-26. PubMed ID: 33158594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.